Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048594912> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W3048594912 endingPage "137" @default.
- W3048594912 startingPage "131" @default.
- W3048594912 abstract "BACKGROUND: The treatment landscape for metastatic clear cell renal cell carcinoma (mRCC) is rapidly changing. It is unknown how adoption of new types of therapies may differ by patient age. OBJECTIVE: To compare trends in first-line therapy use for older (≥70 years) and younger (< 70) patients with mRCC before and after approval of nivolumab in 2015. METHODS: Using the National Cancer Database, we assessed trends in first-line therapy use by calculating the proportion of patients receiving targeted therapy, immunotherapy, or no systemic therapy by year of diagnosis. Initial systemic treatment was compared for patients diagnosed in 2016 with patients diagnosed in 2011 as a control group prior to nivolumab approval. Multivariable regression analysis was used to evaluate the interaction between year of diagnosis and elderly status for use of first-line immunotherapy or targeted therapy. RESULTS: From 2006 to 2016, the proportion of patients receiving any type of systemic therapy increased from 43.7% to 56.5%. On stratified multivariable regression analysis, older patients diagnosed in 2016 were 17.3 times more likely to receive first-line immunotherapy compared to those diagnosed in 2011, while younger patients were 2.3 times more likely. There was no change in targeted therapy use over this time regardless of patient age. CONCLUSIONS: The rate of adoption of first-line immunotherapy was particularly pronounced for elderly compared to younger patients. While first-line use of immunotherapy may have allowed elderly patients to receive systemic therapy that they otherwise would not, the efficacy of these drugs in elderly patients deserves further study." @default.
- W3048594912 created "2020-08-18" @default.
- W3048594912 creator A5027428925 @default.
- W3048594912 creator A5068848162 @default.
- W3048594912 creator A5071054112 @default.
- W3048594912 creator A5074019658 @default.
- W3048594912 creator A5083920381 @default.
- W3048594912 date "2020-09-16" @default.
- W3048594912 modified "2023-09-24" @default.
- W3048594912 title "Trends in Initial Systemic Therapy for Elderly Patients with Metastatic Clear Cell Renal Cell Carcinoma" @default.
- W3048594912 cites W1591088508 @default.
- W3048594912 cites W2066604995 @default.
- W3048594912 cites W2077618811 @default.
- W3048594912 cites W2090192857 @default.
- W3048594912 cites W2129209898 @default.
- W3048594912 cites W2222086386 @default.
- W3048594912 cites W2264794294 @default.
- W3048594912 cites W2766990963 @default.
- W3048594912 cites W2911188335 @default.
- W3048594912 cites W2911812451 @default.
- W3048594912 cites W2913745075 @default.
- W3048594912 cites W946192996 @default.
- W3048594912 doi "https://doi.org/10.3233/kca-200089" @default.
- W3048594912 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7605347" @default.
- W3048594912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33195888" @default.
- W3048594912 hasPublicationYear "2020" @default.
- W3048594912 type Work @default.
- W3048594912 sameAs 3048594912 @default.
- W3048594912 citedByCount "2" @default.
- W3048594912 countsByYear W30485949122021 @default.
- W3048594912 countsByYear W30485949122022 @default.
- W3048594912 crossrefType "journal-article" @default.
- W3048594912 hasAuthorship W3048594912A5027428925 @default.
- W3048594912 hasAuthorship W3048594912A5068848162 @default.
- W3048594912 hasAuthorship W3048594912A5071054112 @default.
- W3048594912 hasAuthorship W3048594912A5074019658 @default.
- W3048594912 hasAuthorship W3048594912A5083920381 @default.
- W3048594912 hasBestOaLocation W30485949122 @default.
- W3048594912 hasConcept C121608353 @default.
- W3048594912 hasConcept C126322002 @default.
- W3048594912 hasConcept C143998085 @default.
- W3048594912 hasConcept C185926286 @default.
- W3048594912 hasConcept C2777472916 @default.
- W3048594912 hasConcept C2777701055 @default.
- W3048594912 hasConcept C2780030458 @default.
- W3048594912 hasConcept C2781230642 @default.
- W3048594912 hasConcept C530470458 @default.
- W3048594912 hasConcept C71924100 @default.
- W3048594912 hasConceptScore W3048594912C121608353 @default.
- W3048594912 hasConceptScore W3048594912C126322002 @default.
- W3048594912 hasConceptScore W3048594912C143998085 @default.
- W3048594912 hasConceptScore W3048594912C185926286 @default.
- W3048594912 hasConceptScore W3048594912C2777472916 @default.
- W3048594912 hasConceptScore W3048594912C2777701055 @default.
- W3048594912 hasConceptScore W3048594912C2780030458 @default.
- W3048594912 hasConceptScore W3048594912C2781230642 @default.
- W3048594912 hasConceptScore W3048594912C530470458 @default.
- W3048594912 hasConceptScore W3048594912C71924100 @default.
- W3048594912 hasIssue "3" @default.
- W3048594912 hasLocation W30485949121 @default.
- W3048594912 hasLocation W30485949122 @default.
- W3048594912 hasLocation W30485949123 @default.
- W3048594912 hasOpenAccess W3048594912 @default.
- W3048594912 hasPrimaryLocation W30485949121 @default.
- W3048594912 hasRelatedWork W2050641956 @default.
- W3048594912 hasRelatedWork W2509001140 @default.
- W3048594912 hasRelatedWork W2529636648 @default.
- W3048594912 hasRelatedWork W2969738919 @default.
- W3048594912 hasRelatedWork W2971237742 @default.
- W3048594912 hasRelatedWork W3025864022 @default.
- W3048594912 hasRelatedWork W3048594912 @default.
- W3048594912 hasRelatedWork W3159453953 @default.
- W3048594912 hasRelatedWork W3160374203 @default.
- W3048594912 hasRelatedWork W3212093395 @default.
- W3048594912 hasVolume "4" @default.
- W3048594912 isParatext "false" @default.
- W3048594912 isRetracted "false" @default.
- W3048594912 magId "3048594912" @default.
- W3048594912 workType "article" @default.